Home/Filings/4/0001140361-25-009513
4//SEC Filing

Short Glenn Frank 4

Accession 0001140361-25-009513

CIK 0001840904other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 7:29 PM ET

Size

6.6 KB

Accession

0001140361-25-009513

Insider Transaction Report

Form 4
Period: 2025-03-14
Short Glenn Frank
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-1432,5000 total
    Common Shares (32,500 underlying)
  • Exercise/Conversion

    Common Shares

    2025-03-14+32,50055,494 total
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. The restricted stock units vested on March 14, 2025.

Issuer

ATAI Life Sciences N.V.

CIK 0001840904

Entity typeother

Related Parties

1
  • filerCIK 0002049070

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 7:29 PM ET
Size
6.6 KB